35 related articles for article (PubMed ID: 32094263)
1. Small-molecule inhibition of kinesin KIF18A reveals a mitotic vulnerability enriched in chromosomally unstable cancers.
Payton M; Belmontes B; Hanestad K; Moriguchi J; Chen K; McCarter JD; Chung G; Ninniri MS; Sun J; Manoukian R; Chambers S; Ho SM; Kurzeja RJM; Edson KZ; Dahal UP; Wu T; Wannberg S; Beltran PJ; Canon J; Boghossian AS; Rees MG; Ronan MM; Roth JA; Minocherhomji S; Bourbeau MP; Allen JR; Coxon A; Tamayo NA; Hughes PE
Nat Cancer; 2024 Jan; 5(1):66-84. PubMed ID: 38151625
[TBL] [Abstract][Full Text] [Related]
2. Overlaid Transcriptional and Proteome Analyses Identify Mitotic Kinesins as Important Targets of Arylsulfonamide-Mediated RBM39 Degradation.
Coomar S; Mota P; Penson A; Schwaller J; Abdel-Wahab O; Gillingham D
Mol Cancer Res; 2023 Aug; 21(8):768-778. PubMed ID: 37255411
[TBL] [Abstract][Full Text] [Related]
3. Selective and ATP-competitive kinesin KIF18A inhibitor suppresses the replication of influenza A virus.
Cho YB; Hong S; Kang KW; Kang JH; Lee SM; Seo YJ
J Cell Mol Med; 2020 May; 24(10):5463-5475. PubMed ID: 32253833
[TBL] [Abstract][Full Text] [Related]
4. Targeting the Mitotic Kinesin KIF18A in Chromosomally Unstable Cancers: Hit Optimization Toward an In Vivo Chemical Probe.
Tamayo NA; Bourbeau MP; Allen JR; Ashton KS; Chen JJ; Kaller MR; Nguyen TT; Nishimura N; Pettus LH; Walton M; Belmontes B; Moriguchi J; Chen K; McCarter JD; Hanestad K; Chung G; Ninniri MSS; Sun J; Poppe L; Spahr C; Hui J; Jia L; Wu T; Dahal UP; Edson KZ; Payton M
J Med Chem; 2022 Mar; 65(6):4972-4990. PubMed ID: 35286090
[TBL] [Abstract][Full Text] [Related]
5. KIF18A knockdown reduces proliferation, migration, invasion and enhances radiosensitivity of esophageal cancer.
Qian LX; Cao X; Du MY; Ma CX; Zhu HM; Peng Y; Hu XY; He X; Yin L
Biochem Biophys Res Commun; 2021 Jun; 557():192-198. PubMed ID: 33872988
[TBL] [Abstract][Full Text] [Related]
6. Chromosomally unstable tumor cells specifically require KIF18A for proliferation.
Marquis C; Fonseca CL; Queen KA; Wood L; Vandal SE; Malaby HLH; Clayton JE; Stumpff J
Nat Commun; 2021 Feb; 12(1):1213. PubMed ID: 33619254
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive Pan-Cancer Analysis of KIF18A as a Marker for Prognosis and Immunity.
Liu T; Yang K; Chen J; Qi L; Zhou X; Wang P
Biomolecules; 2023 Feb; 13(2):. PubMed ID: 36830695
[TBL] [Abstract][Full Text] [Related]
8. Prognostic Biomarker KIF18A and Its Correlations With Immune Infiltrates and Mitosis in Glioma.
Tao BY; Liu YY; Liu HY; Zhang ZH; Guan YQ; Wang H; Shi Y; Zhang J
Front Genet; 2022; 13():852049. PubMed ID: 35591854
[No Abstract] [Full Text] [Related]
9. Novel KIF18A Inhibitors for Treating Cancer.
Sabnis RW
ACS Med Chem Lett; 2020 Nov; 11(11):2079-2080. PubMed ID: 33214814
[No Abstract] [Full Text] [Related]
10. RNA binding protein PUM2 promotes hepatocellular carcinoma proliferation and apoptosis via binding to the 3'UTR of BTG3.
Liu Z; Lv C
Oncol Lett; 2022 Oct; 24(4):346. PubMed ID: 36072004
[TBL] [Abstract][Full Text] [Related]
11. Kinesins in Mammalian Spermatogenesis and Germ Cell Transport.
Yao M; Qu H; Han Y; Cheng CY; Xiao X
Front Cell Dev Biol; 2022; 10():837542. PubMed ID: 35547823
[TBL] [Abstract][Full Text] [Related]
12. Role of PUM RNA-Binding Proteins in Cancer.
Smialek MJ; Ilaslan E; Sajek MP; Jaruzelska J
Cancers (Basel); 2021 Jan; 13(1):. PubMed ID: 33401540
[TBL] [Abstract][Full Text] [Related]
13. Kinesin KIF18A is a novel PUM-regulated target promoting mitotic progression and survival of a human male germ cell line.
Smialek MJ; Kuczynska B; Ilaslan E; Janecki DM; Sajek MP; Kusz-Zamelczyk K; Jaruzelska J
J Cell Sci; 2020 Apr; 133(7):. PubMed ID: 32094263
[TBL] [Abstract][Full Text] [Related]
14. Characterization of RNP Networks of PUM1 and PUM2 Post-Transcriptional Regulators in TCam-2 Cells, a Human Male Germ Cell Model.
Smialek MJ; Ilaslan E; Sajek MP; Swiercz A; Janecki DM; Kusz-Zamelczyk K; Wozniak T; Kotecki M; Handschuh L; Figlerowicz M; Jaruzelska J
Cells; 2020 Apr; 9(4):. PubMed ID: 32316190
[TBL] [Abstract][Full Text] [Related]
15. PUM1 and PUM2 exhibit different modes of regulation for SIAH1 that involve cooperativity with NANOS paralogues.
Sajek M; Janecki DM; Smialek MJ; Ginter-Matuszewska B; Spik A; Oczkowski S; Ilaslan E; Kusz-Zamelczyk K; Kotecki M; Blazewicz J; Jaruzelska J
Cell Mol Life Sci; 2019 Jan; 76(1):147-161. PubMed ID: 30269240
[TBL] [Abstract][Full Text] [Related]
16. Mammalian Pum1 and Pum2 Control Body Size via Translational Regulation of the Cell Cycle Inhibitor Cdkn1b.
Lin K; Qiang W; Zhu M; Ding Y; Shi Q; Chen X; Zsiros E; Wang K; Yang X; Kurita T; Xu EY
Cell Rep; 2019 Feb; 26(9):2434-2450.e6. PubMed ID: 30811992
[TBL] [Abstract][Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
